112. Thalassemia and Globin Gene Regulation: Poster II

Atrial Fibrillation Prevalence and Its Management in Transfusion-Dependent Thalassemias: The Fathal Study

Efficacy of Low Dose Vs Standard Dose of Thalidomide in Patients with Transfusion-Dependent Thalassemia (TDT): A Non-Inferiority Trial

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYO

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Real-World Characteristics, Treatment Utilization, and Transfusion Burden in Patients with ß-Thalassemia Initiating Luspatercept: A US Cohort Study

Pituitary and Pancreatic Iron Is Present at an Early Age in Transfused Patients with Alpha Thalassemia Major

Effect of Luspatercept on Erythropoiesis and Fetal Hemoglobin in ß-Transfusion-Dependent Thalassemia Patients: A Real-Life Experience

Flu Induced Acute Chest Syndrome in Sickle Cell Disease Mice

Improvement in Iron Burden in Patients with Transfusion-Dependent ß-Thalassemia (TDT) Treated with Betibeglogene Autotemcel (Beti-cel) Gene Therapy: U